Netherlands' Qiagen Q3 sales, adjusted EPS top outlook; suspends 2026 guidance
Netherlands' Qiagen Q3 sales, adjusted EPS top outlook; suspends 2026 guidance
Overview
Netherlands molecular diagnostics firm's Q3 net sales rose 3% yr/yr, exceeding company outlook
Adjusted diluted EPS for Q3 rose to $0.65, above company outlook
Company suspended 2026 financial guidance due to pending EQT Private Equity transaction
Outlook
Qiagen has suspended its 2026 outlook due to the pending EQT Private Equity transaction
Result Drivers
CONSUMABLES GROWTH - Consumables and related revenues rose 3% CER and made up 91% of sales, while instrument sales rose 1% CER
MARGIN IMPROVEMENT - Higher-margin consumables and efficiency gains contributed to increased adjusted operating income margin
GROWTH PILLARS - Sales from QIAGEN's growth pillars rose 7% CER to $415 mln, partly offset by a 7% CER decline in the rest of the portfolio
Company press release: ID:nBw48f1XSa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 EPS |
| $0.51 |
|
Q3 Adjusted Operating Income Margin |
| 30.40% |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the biotechnology & medical research peer group is "buy."
Wall Street's median 12-month price target for QIAGEN N.V. is €44.61, about 1.4% below its November 4 closing price of €45.23
The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 16 three months ago
Reuters Recommended Reads
Nov 3 - Netherlands' Philips slightly misses Q3 revenue estimates, maintains 2026 forecast
Nov 3 - Life sciences tech firm Waters' Q3 revenue, adjusted EPS beat estimates
Nov 3 - Revvity Q3 revenue beats estimates, raises FY guidance
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)